John K. Chan, MD
Regional Director of Gynecologic Oncology
California Pacific & Palo Alto Medical Foundation / Sutter Research Institute
3838 California Street
#410
San Francisco,
CA
USA
94115
Papers:
9
Differences in presentation and survival of Asians versus Caucasians with ovarian cancer: a Gynecologic Oncology Group ancillary study of 7,914 patients
128
Disease stabilization vs. response after bevacizumab treatment in recurrent ovarian cancer: how do we determine clinical efficacy?
180
The increase in early detection and associated improved survival of cervical cancer in the US: a ten-year study of 6,414 patients
190
Trends in FDA approval of oncology drugs: have we made progress?
209
Correlation between type I uterine cancer and diet and lifestyle in US-born versus immigrant Asian subgroups
211
Types of surgery for morbidly obese endometrial cancer patients in the US: how and where do we make the largest impact?
212
Differences in survival between clear cell uterine and ovarian carcinoma patients
280
The increase in hospital charges associated with ovarian cancer treatment: an economic analysis of 83,552 patients
351
The use of electronic health record-based tools to improve cervical cancer screening compliance in a large community-based health care organization
385
Differences in BMI and physical activity in Whites vs. Asians in California in association with type I uterine cancer
411
The role of lymphadenectomy and radiation therapy for malignant mixed Müllerian uterine cancers
A phase II evaluation of sunitinib (SU11248) in the treatment of persistent or recurrent clear cell ovarian carcinoma: an NRG oncology / gynecologic oncology group study